<?xml version="1.0" encoding="UTF-8"?>
<ref id="B11">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Harmatz</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Jonas</surname>
    <given-names>M. M.</given-names>
   </name>
   <name>
    <surname>Kwiatkowski</surname>
    <given-names>J. L.</given-names>
   </name>
   <name>
    <surname>Wright</surname>
    <given-names>E. C.</given-names>
   </name>
   <name>
    <surname>Fischer</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Vichinsky</surname>
    <given-names>E.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2008</year>). 
  <article-title>Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia</article-title>. 
  <source>Haematologica</source>
  <volume>93</volume>, 
  <fpage>1247</fpage>â€“
  <lpage>1251</lpage>. 
  <pub-id pub-id-type="doi">10.3324/haematol.12352</pub-id>
  <?supplied-pmid 18556414?>
  <pub-id pub-id-type="pmid">18556414</pub-id>
 </mixed-citation>
</ref>
